US glaucoma sufferers get Medicare relief:
This article was originally published in Clinica
Executive Summary
Medicare has begun covering an annual dilated eye examination for elderly beneficiaries at high risk of glaucoma, federal health officials announced last week. The new coverage decision, effective January 1 2002, is consistent with recommendations from the National Eye Institute as well as from eyecare professional organisations and consumer groups. High-risk persons are defined as those with diabetes; those with a family history of glaucoma and African Americans aged 50 and above. The dilated eye test involves putting drops into the eye to enlarge the pupils so that an optometrist or ophthalmologist can see further inside the eye to check for signs of glaucoma.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.